NOBEL BIOCARE DANMARK A/S: Financial statements 2018
CVR: 28293364
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,336,703 and a net result of DKK 419,851 compared with DKK 580,387 the year before. That is a decrease of 11.6% compared with the year before. Equity in the 2018 report amounted to DKK 4,855,151. The solvency ratio was 19.7%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,336,703
- Profit/Loss
- DKK 419,851
- Equity
- DKK 4,855,151
- Total Assets
- DKK 24,673,119
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 3.3 mio. | 420 t. | 4.9 mio. | 3 |
| 2017 | - | 3.8 mio. | 580 t. | 4.4 mio. | 4 |
| 2016 | - | 6.3 mio. | 894 t. | 3.9 mio. | 4 |
| 2015 | - | 5.5 mio. | 578 t. | 3 mio. | - |
| 2014 | - | 5.2 mio. | 430 t. | 2.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
NOBEL BIOCARE DANMARK A/S has published its annual report for 2017. Gross profit came to DKK 3,775,166, and the net result was DKK 580,387.
As of January 15, 2018, Jens Henrik Nedoh is registered as director of NOBEL BIOCARE DANMARK A/S.
As of January 15, 2018, Jan Jerne has stepped down as director of NOBEL BIOCARE DANMARK A/S.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.